To date, several pharmacological reports have shown that PLAB induces growth inhibition, cell cycle arrest, and apoptosis in a number of cancer cell lines including breast cancer, colon cancer, hepatocellular carcinoma, melanoma cells [9], liver cancer, cervical cancer, gastric cancer, lung cancer, and leukemia [10, 11]. Here, GDF15 is linked to breast cancer.